Amphotericin B susceptibility testing of Candida lusitaniae isolates by flow cytofluorometry:: comparison with the Etest and the NCCLS broth macrodilution method

被引:15
作者
Favel, A
Peyron, F
De Méo, M
Michel-Nguyen, A
Carrière, J
Chastin, C
Regli, P
机构
[1] Univ Mediterranee, Lab Bot Cryptogamie & Biol Cellulaire, Fac Pharm, EA 864, F-13385 Marseille 5, France
[2] Univ Mediterranee, Lab Biogenotoxicol & Mutagenese Environm, Fac Pharm, EA 1784, F-13385 Marseille, France
[3] CHU Nord, Lab Bacteriol & Parasitol, F-13015 Marseille, France
[4] CHU Pitie Salpetriere, Serv Parasitol Mycol, F-75651 Paris 13, France
关键词
D O I
10.1093/jac/43.2.227
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A flow cytofluorometric susceptibility test (FCST) was used for rapid determination of the susceptibility of Candida lusitaniae isolates to amphotericin B. The test is based on the decrease in fluorescence intensity of cells stained with 3,3'-dipentyloxacarbocyanine iodide (DiOC(5)(3)), a membrane potential-sensitive cationic dye, after drug treatment. A total of 58 C. lusitaniae clinical isolates including strains known to be amphotericin B-resistant on the basis of in-vivo and/or in-vitro data were tested. MICs were determined concurrently by the NCCLS broth macrodilution method and the Etest, both with antibiotic medium 3. Regression analysis demonstrated that the data from the FCST and the Etest were better correlated (r = 0.93, n = 59, P < 0.001) than those from the FCST and the NCCLS method (r = 0.63, n = 59, P < 0.001). The FCST readily identified a series of putatively susceptible and resistant isolates. Our study points out the advantages of the flow cytometry approach in antifungal susceptibility testing of yeasts, since speed remains a major problem in conventional tests.
引用
收藏
页码:227 / 232
页数:6
相关论文
共 20 条
[1]  
[Anonymous], 1992, M27P NCCLS
[2]   EMERGENCE OF A NEW OPPORTUNISTIC PATHOGEN, CANDIDA-LUSITANIAE [J].
BLINKHORN, RJ ;
ADELSTEIN, D ;
SPAGNUOLO, PJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (02) :236-240
[3]   AMPHOTERICIN-B - CURRENT UNDERSTANDING OF MECHANISMS OF ACTION [J].
BRAJTBURG, J ;
POWDERLY, WG ;
KOBAYASHI, GS ;
MEDOFF, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (02) :183-188
[4]  
Carter Elizabeth A., 1993, P111
[5]  
Espinel-Ingroff Ana, 1996, Clinical Microbiology Newsletter, V18, P161, DOI 10.1016/0196-4399(96)88204-3
[6]   In-vitro susceptibility pattern of Candida lusitaniae and evaluation of the Etest method [J].
Favel, A ;
MichelNguyen, A ;
Chastin, C ;
Trousson, F ;
Penaud, A ;
Regli, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (05) :591-596
[7]   RECENT ADVANCES OF FLOW-CYTOMETRY IN FUNDAMENTAL AND APPLIED MICROBIOLOGY [J].
FOUCHET, P ;
JAYAT, C ;
HECHARD, Y ;
RATINAUD, MH ;
FRELAT, G .
BIOLOGY OF THE CELL, 1993, 78 (1-2) :95-109
[8]   Resistance to fluconazole and amphotericin in Candida albicans from AIDS patients [J].
Kelly, SL ;
Lamb, DC ;
Kelly, DE ;
Loeffler, J ;
Einsele, H .
LANCET, 1996, 348 (9040) :1523-1524
[9]   Lot-to-lot variability of antibiotic medium 3 used for testing susceptibility of Candida isolates to amphotericin B [J].
LozanoChiu, M ;
Nelson, PW ;
Lancaster, M ;
Pfaller, MA ;
Rex, JH .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (01) :270-272